The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BANK AMER CORP *W EXP 01/16/201 060505146 23,184 2,330,000 SH   SOLE 2,330,000 0 0
HERBALIFE LTD NOTE 2.000% 8/1 42703MAB9 2,295 2,500,000 PRN   SOLE 2,500,000 0 0
ISHARES TR CHINA LG-CAP ETF 464287184 11,368 327,500 SH Put SOLE 327,500 0 0
KINDER MORGAN INC DEL *W EXP 05/25/201 49456B119 3 481,600 SH   SOLE 481,600 0 0
MGIC INVT CORP WIS NOTE 2.000% 4/0 552848AE3 3,699 2,500,000 PRN   SOLE 2,500,000 0 0
MONSANTO CO NEW COM 61166W101 23,672 225,000 SH Call SOLE 225,000 0 0
NETFLIX INC COM 64110L106 13,742 111,000 SH Put SOLE 111,000 0 0
NETFLIX INC COM 64110L106 9,904 80,000 SH Call SOLE 80,000 0 0
PANDORA MEDIA INC NOTE 1.750%12/0 698354AB3 5,148 5,000,000 PRN   SOLE 5,000,000 0 0
PROSHARES TR II ULTRA VIX SHORT 74347W254 1,528 174,600 SH Put SOLE 174,600 0 0
TESLA MTRS INC NOTE 1.250% 3/0 88160RAC5 2,607 3,000,000 PRN   SOLE 3,000,000 0 0
VALEANT PHARMACEUTICALS INTL COM 91911K102 944 65,000 SH Call SOLE 65,000 0 0
VALEANT PHARMACEUTICALS INTL COM 91911K102 1,496 103,000 SH   SOLE 103,000 0 0
ZIONS BANCORPORATION *W EXP 11/14/201 989701131 253 29,245 SH   SOLE 29,245 0 0